Related Experiment Video
Updated: Jul 17, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Asthma and COVID-19: a controversial relationship.
Carlos A Dounce-Cuevas1, Angélica Flores-Flores1,2, Mariana S Bazán1
1Tecnologico de Monterrey, Escuela de Medicina y Ciencias de la Salud, 14380, Mexico City, Mexico.
COVID-19 outcomes vary in asthma patients due to immune responses. Lockdown measures significantly decreased asthma and acute respiratory infection cases, suggesting a link between infections and asthma incidence.
Area of Science:
- Immunology
- Epidemiology
- Respiratory Medicine
Background:
- Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, causing COVID-19, presents diverse clinical outcomes influenced by patient immune responses.
- A cytokine storm, characterized by excessive inflammatory mediators, can arise from an ineffective T helper (Th)-1 response, leading to tissue damage.
- Asthma patients exhibit variable COVID-19 outcomes due to disease heterogeneity, with Th2 responses potentially mitigating cytokine storms, while severe neutrophilic asthma is linked to poor outcomes.
Purpose of the Study:
- To explore the complex interplay between SARS-CoV-2 infection, immune responses, and asthma patient outcomes.
- To investigate the impact of COVID-19 lockdown measures on asthma and acute respiratory infection (ARI) epidemiology.
- To understand the relationship between social distancing, ARIs, and asthma incidence.
Main Methods:
- Review of clinical manifestations and immune responses in SARS-CoV-2 infected individuals, focusing on asthma patients.
- Analysis of asthma and ARI incidence data in relation to COVID-19 lockdown stringency in Mexican states.
- Comparison of pre- and post-lockdown epidemiological trends for asthma and other diseases.
Main Results:
- The T2 response in allergic asthma may prevent cytokine storms in COVID-19, while IL-13 can reduce SARS-CoV-2 entry by downregulating ACE2 receptors.
- Severe neutrophilic asthma is associated with adverse COVID-19 outcomes.
- A significant decrease in asthma and ARI cases was observed during the COVID-19 lockdown, with a notable link between social distancing and reduced incidence.
- Unlike other diseases, asthma and ARI cases did not fully recover to pre-pandemic levels post-lockdown, with slight increases upon return to in-person activities.
Conclusions:
- Asthma patient outcomes during the COVID-19 pandemic are multifactorial, influenced by specific immune responses and disease severity.
- COVID-19 lockdown measures, particularly school closures and social distancing, were strongly associated with a reduction in asthma and acute respiratory infection cases.
- Acute respiratory infections appear intrinsically linked to asthma exacerbations and incidence, highlighting the importance of infection control measures.
More Related Videos
Related Concept Videos
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-IV: Nursing Management
First, in...

